• Users Online: 95
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2021| July-September  | Volume 4 | Issue 3  
    Online since October 8, 2021

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
MUSINGS
COVID-19 vaccine hesitancy in India
Mihir Tusharbhai Dani, Arjun Gurmeet Singh, Pankaj Chaturvedi
July-September 2021, 4(3):437-442
DOI:10.4103/crst.crst_219_21  
  2,474 258 -
DRUG REVIEW
Sotorasib – an inhibitor of KRAS p.G12c mutation in advanced non-small cell carcinoma: A narrative drug review
Amit Kumar Agrawal, Ramya Pragya, Amit Choudhary, Anuj Gupta, Kuraparthy Sambasivaiah, Bal Krishna Mishra, Satvik Khaddar, Akhil Kapoor
July-September 2021, 4(3):524-528
DOI:10.4103/crst.crst_145_21  
  1,952 136 -
REVIEW ARTICLE-BIOMARKER SERIES
Biomarker series: KRAS- A narrative review
Ullas Batra, Shrinidhi Nathany
July-September 2021, 4(3):516-523
DOI:10.4103/crst.crst_189_21  
  1,800 115 -
ORIGINAL ARTICLES
Dietary risk factors for colorectal cancer: A hospital-based case–control study
Tasneef Zargar, Dinesh Kumar, Bhavna Sahni, Nadeem Shoket, Kiran Bala, Shabab Angurana
July-September 2021, 4(3):479-485
DOI:10.4103/crst.crst_116_21  
  1,486 131 -
MUSINGS
Thwart embers before they become an inferno
Suvir Singh, Rintu Sharma
July-September 2021, 4(3):433-434
DOI:10.4103/crst.crst_105_21  
  1,453 111 -
ORIGINAL ARTICLES
Conformal radiation therapy versus volumetric arc therapy in high dose concurrent chemoradiotherapy for carcinoma esophagus: A retrospective analysis
Tapas Kumar Dora, Jayashree Deshmukh, Abhishek Chatterjee, Alok Goel, Subhadeep Bose, Avtar Singh, Amit Saini, Shefali Pahwa, Sarbani Ghosh Laskar, Jai Prakash Agarwal, Shyam Kishore Shrivastava, Rakesh Kapoor
July-September 2021, 4(3):456-465
DOI:10.4103/crst.crst_123_21  
  1,238 91 -
MOLECULAR TUMOR BOARD
Concurrent EGFR and PIK3CA mutations in non-small-cell lung cancer
Akhil Kapoor, Vanita Noronha, Omshree Anil Shetty, Lakhan Kashyap, Amit Kumar, Pratik Chandrani, Vijay M Patil, Amit Joshi, Nandini Menon, Rajiv Kumar, Ramya Pragya, Kumar Prabhash
July-September 2021, 4(3):541-546
DOI:10.4103/crst.crst_207_21  
  1,228 87 -
LETTERS TO EDITOR
Strategies aimed at overcoming COVID-19 vaccine hesitancy among oncologic patients
Cynthia Villarreal-Garza, Bryan F Vaca-Cartagena, Andrea Becerril-Gaitan, Ana S Ferrigno
July-September 2021, 4(3):561-562
DOI:10.4103/crst.crst_173_21  
  1,222 51 -
REVIEW ARTICLE
Vaccination practices, efficacy, and safety in adults with cancer: A narrative review
Laboni Sarkar, Vasu Babu Goli, Nandini Menon, Vijay Maruti Patil, Vanita Noronha, Kumar Prabhash
July-September 2021, 4(3):505-515
DOI:10.4103/crst.crst_156_21  
  1,180 69 -
ORIGINAL ARTICLES
Totally implantable venous access devices in cancer chemotherapy: A retrospective analysis of 8421 catheter days in a tertiary cancer center
Jashma Chandveettil, Abhay K Kattepur, Nizamudheen Mangalasseri Pareekutty, John J Alapatt, Appumathi Rogarajan Mathiyazhakan, Ratheesan Kumbakara, Vivek M Ananthakrishna Murthy, Satheesan Balasubramanian
July-September 2021, 4(3):449-455
DOI:10.4103/crst.crst_119_21  
  1,122 89 -
MUSINGS
The road most traveled…
Santosh Menon
July-September 2021, 4(3):435-436
DOI:10.4103/crst.crst_171_21  
  1,091 87 -
ORIGINAL ARTICLES
Patterns of smoking among oncologists of Eastern India: A questionnaire-based survey
Koushik Chatterjee, Amitabh Ray, Arup Chakraborty
July-September 2021, 4(3):443-448
DOI:10.4103/crst.crst_133_21  
  973 83 -
Clinical presentation and pattern of care for sarcomatoid variant of squamous cell carcinoma of the head-and-neck region: A retrospective study
Adhara Chakraborthy, Shivakumar Thiagarajan, Munita Bal, Devendra Chaukar
July-September 2021, 4(3):466-471
DOI:10.4103/crst.crst_148_21  
  898 71 -
ORIGINAL ARTICLE: GERIATRIC ONCOLOGY SECTION
Oncologists' perceptions of the need for assessing individual domains in the geriatric assessment and worthwhile outcomes in treating older patients with cancer: A questionnaire-based survey
Vanita Noronha, Devanshi Kalra, Anant Ramaswamy, Shreya C Gattani, Nandini Menon, Vijay M Patil, Kumar Prabhash
July-September 2021, 4(3):492-498
DOI:10.4103/crst.crst_215_21  
  878 67 -
IMAGE CHALLENGE
Potato in the parapharyngeal space
Gauri Bornak, Vasundhara Patil, Abhishek Mahajan
July-September 2021, 4(3):547-550
DOI:10.4103/crst.crst_152_21  
  832 51 -
EDITORIALS
Radiation therapy in esophageal cancer: Shifting paradigms
Kaustav Talapatra
July-September 2021, 4(3):538-540
DOI:10.4103/crst.crst_217_21  
  835 44 -
ORIGINAL ARTICLE: REAL WORLD DATA
Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center
Joydeep Ghosh, Sayantika Dey, Debapriya Mandal, Sandip Ganguly, Bivas Biswas, Deepak Dabkara, Anik Ghosh, Basumita Chakraborty, Arunava Roy, Shweta Rai, Sonia Mathai, Jaydip Bhaumik
July-September 2021, 4(3):486-491
DOI:10.4103/crst.crst_124_21  
  759 40 -
RESIDENT CORNER
Throwback to when it all started: Part two
K Alok Shetty
July-September 2021, 4(3):529-532
DOI:10.4103/crst.crst_146_21  
  758 32 -
LETTERS TO EDITOR
Combating vaccine hesitancy: A call to implement healthcare worker training in patient counseling skills
Arati K Kelekar, Victoria C Lucia, Nelia M Afonso
July-September 2021, 4(3):562-563
DOI:10.4103/crst.crst_177_21  
  738 31 -
We need to tackle vaccine hesitancy in our patients with cancer
Abdul Ghafur
July-September 2021, 4(3):564-565
DOI:10.4103/crst.crst_176_21  
  711 32 -
COVID-19 vaccine-related skin rash : A case report
Sachin Babanrao Dhumal, Amar Patil, Ashwini More, Sujeet Kamtalwar, Anand Gosavi, Manisha Chandak, Navin Khattry, Sudeep Gupta, Prasanth Bhat
July-September 2021, 4(3):555-556
DOI:10.4103/crst.crst_143_21  
  636 47 -
STATISTICAL RESOURCE
Logistic regression: A simple primer
Ankita Pal
July-September 2021, 4(3):551-554
DOI:10.4103/crst.crst_164_21  
  616 55 -
ORIGINAL ARTICLES
Retrospective analysis of histopathological spectrum of premalignant and malignant colorectal lesions
Henisha T Tahiliani, Asha P Purohit, Shashank C Desai, Puja Bhavesh Jarwani
July-September 2021, 4(3):472-478
DOI:10.4103/crst.crst_87_21  
  616 50 -
LETTERS TO EDITOR
Value-based pricing for cancer drugs in India
Shankar Prinja, Nidhi Gupta
July-September 2021, 4(3):559-560
DOI:10.4103/crst.crst_200_21  
  622 42 -
Bevacizumab in recurrent glioma: Variable doses, volatile benefits
Sujith Kumar Mullapally, Pankaj Kumar Panda
July-September 2021, 4(3):576-577
DOI:10.4103/crst.crst_172_21  
  608 25 -
EDITORIALS
Healing the healers
Arjun Gurmeet Singh, Pankaj Chaturvedi
July-September 2021, 4(3):533-535
DOI:10.4103/crst.crst_216_21  
  590 37 -
LETTERS TO EDITOR
Analysis of RetinaNet experiments for COVID-19 detection using computed tomography scan images
Kaustubh Kulkarni
July-September 2021, 4(3):596-597
DOI:10.4103/crst.crst_178_21  
  592 32 -
Pitfalls of generalizing the causes of COVID-19 vaccine hesitancy among patients with cancer
Sharmila Pimple, Gauravi Mishra
July-September 2021, 4(3):566-567
DOI:10.4103/crst.crst_163_21  
  548 47 -
POETRY IN ONCOLOGY
Warrior
Disha Tiwari
July-September 2021, 4(3):499-499
DOI:10.4103/crst.crst_137_21  
  544 32 -
LETTERS TO EDITOR
Becoming an oncologist: What is the optimal training duration?
Vinay Mathew Thomas, Neil Roy, Aju Mathew
July-September 2021, 4(3):556-559
DOI:10.4103/crst.crst_188_21  
  536 35 -
EDITORIALS
Totally implantable venous access devices: Necessity or luxury?
Swapnil Patel, Preeti Vijayakumaran
July-September 2021, 4(3):536-537
DOI:10.4103/crst.crst_221_21  
  536 28 -
LETTERS TO EDITOR
The oncologist as COVID-19 vaccine teacher and logistician: A pathway to better outcomes
David A Potter
July-September 2021, 4(3):567-568
DOI:10.4103/crst.crst_194_21  
  521 29 -
PATIENT/CAREGIVER CORNER
The “CANCER” (Shush! Don't use the word) Chronicles
Sanjyot Parasnis
July-September 2021, 4(3):500-502
DOI:10.4103/crst.crst_154_21  
  520 30 -
LETTERS TO EDITOR
HER2 alterations in non-small cell lung cancer: More unknowns than knowns!
Senthil J Rajappa
July-September 2021, 4(3):587-588
DOI:10.4103/crst.crst_168_21  
  522 22 1
RAS mutations and colorectal cancer: Testing and precision medicine
Syed Sameer Aga, Saniya Nissar
July-September 2021, 4(3):580-581
DOI:10.4103/crst.crst_165_21  
  474 27 -
Willingness and hesitancy toward COVID-19 vaccination among patients with cancer
Jaison Jacob, Rakesh Vadakkethil Radhakrishnan, Alwin Issac
July-September 2021, 4(3):563-564
DOI:10.4103/crst.crst_161_21  
  458 24 -
Authors' reply to Villarreal-Garza et al., Kelekar et al., Jacob et al., Pimple et al., Ghafur, and Potter
George Abraham, Vanita Noronha, Kumar Prabhash
July-September 2021, 4(3):568-570
DOI:10.4103/crst.crst_211_21  
  418 44 -
COVID-19 in children with hematological disorders – Outcomes, impact on management, and the way forward
Nihar Desai, Anshul Gupta, Pankti Mehta
July-September 2021, 4(3):589-590
DOI:10.4103/crst.crst_187_21  
  422 20 -
Need for a national consortium of clinical registries of cancer and COVID-19 for vaccine surveillance
Sharmila Pimple, Gauravi Mishra
July-September 2021, 4(3):570-571
DOI:10.4103/crst.crst_180_21  
  406 29 -
Are we training enough?
Keduovinuo Keditsu
July-September 2021, 4(3):574-575
DOI:10.4103/crst.crst_181_21  
  402 25 -
PATIENT/CAREGIVER CORNER
Journey to life
Richa Chaudhary
July-September 2021, 4(3):503-504
DOI:10.4103/crst.crst_158_21  
  396 30 -
LETTERS TO EDITOR
Are the elderly from India different from the rest of the world? Data in patients with cancer on immunotherapy
Amish D Vora
July-September 2021, 4(3):584-585
DOI:10.4103/crst.crst_198_21  
  402 23 -
A perfect biomarker for immune checkpoint inhibition - An elusive goal?
Shikhar Kumar
July-September 2021, 4(3):594-595
DOI:10.4103/crst.crst_191_21  
  400 25 -
Advanced lung cancer: The scope(s) of the pulmonologist!
Jayamol Revendran, Sujith Kumar Mullapally
July-September 2021, 4(3):599-600
DOI:10.4103/crst.crst_214_21  
  374 32 -
Adjuvant olaparib in germline BRCA-mutated breast cancer – Standard of care for all?
Shuvadeep Ganguly, Ajay Gogia
July-September 2021, 4(3):600-601
DOI:10.4103/crst.crst_202_21  
  374 25 -
Can patients aged 60 years and over be called elderly?
Tarini Prasad Sahoo
July-September 2021, 4(3):582-583
DOI:10.4103/crst.crst_183_21  
  376 19 -
Endobronchial ultrasound-transbronchial needle aspiration: It's prime time
Ria S Shah, Preyas J Vaidya, Prashant N Chhajed
July-September 2021, 4(3):572-573
DOI:10.4103/crst.crst_182_21  
  374 21 -
Polypharmacy in the elderly on immunotherapy: Problem or opportunity?
Ajit Venniyoor
July-September 2021, 4(3):583-584
DOI:10.4103/crst.crst_184_21  
  370 21 -
Evolving immunotherapy approaches and their efficacy based on gender of the patient: A reflection
Kuraparthy Sambasivaiah, Bipinesh Sansar
July-September 2021, 4(3):593-594
DOI:10.4103/crst.crst_175_21  
  362 29 -
Authors' reply to Kulkarni
K S S. Bharadwaj, Vivek Punia, M L V. Apparao, Abhishek Mahajan
July-September 2021, 4(3):598-599
DOI:10.4103/crst.crst_213_21  
  346 43 -
The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not?
Arpit Jain, Srujana Joga, Amrith B Patel
July-September 2021, 4(3):579-580
DOI:10.4103/crst.crst_190_21  
  368 14 -
Authors' reply to Pimple et al., Ghafur, and Potter
Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Nitin Bansal
July-September 2021, 4(3):571-572
DOI:10.4103/crst.crst_209_21  
  362 19 -
Authors' reply to Shah et al. and Keditsu
Jashma Chandveettil, Nizamudheen Mangalasseri Pareekutty, Abhay K Kattepur
July-September 2021, 4(3):575-576
DOI:10.4103/crst.crst_199_21  
  352 20 -
Recurrent glioblastoma and bevacizumab: Issues and prospects
Richa Chauhan
July-September 2021, 4(3):577-578
DOI:10.4103/crst.crst_185_21  
  348 16 -
Low burden of COVID-19 disease in children with cancer and hematologic illnesses
Deepika Thacker
July-September 2021, 4(3):590-591
DOI:10.4103/crst.crst_174_21  
  340 21 -
Extending adjuvant endocrine therapy in hormone receptor-positive breast cancer: An Indian perspective
Shuvadeep Ganguly, Ajay Gogia
July-September 2021, 4(3):602-603
DOI:10.4103/crst.crst_203_21  
  336 23 -
Authors' reply to Sansar et al. and Kumar
Akhil Kapoor, Vanita Noronha, Kumar Prabhash
July-September 2021, 4(3):595-596
DOI:10.4103/crst.crst_195_21  
  311 34 -
Authors' reply to Sahoo, Veniyoor, and Vora
George M Abraham, Vanita Noronha, Kumar Prabhash
July-September 2021, 4(3):585-587
DOI:10.4103/crst.crst_210_21  
  304 32 -
Authors' reply to Rajappa
Suresh Kumar Bondili, Vanita Noronha
July-September 2021, 4(3):588-589
DOI:10.4103/crst.crst_193_21  
  308 26 -
Authors' reply to Thacker and Desai et al.
Swati Bhayana, Manas Kalra, Pallavi Sachdeva, Anupam Sachdeva
July-September 2021, 4(3):592-592
DOI:10.4103/crst.crst_220_21  
  293 22 -